ArticleFrontiers in physiology2018

Drug Repurposing for Duchenne Muscular Dystrophy: The Monoamine Oxidase B Inhibitor Safinamide Ameliorates the Pathological Phenotype in

Libero Vitiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.